Protein Arginine Methyltransferase 6 Regulated Odontogenic Differentiation and Mitochondrial Function of Stem Cells from Apical Papilla Through its Nuclear Localization Sequence via β-catenin Pathway Authors: Wanhao Yan, Xiaoli Guo, Bingqi Zhao, Yongkang Li, Zhe Shen, Ruitang Shi, Chen Zhang Published: 2026 ABSTRACT ObjectivesOdontogenic differentiation of stem cells from apical papilla (SCAPs) is critical for pulp regeneration therapy. Protein arginine methyltransferase 6 (PRMT6) plays an important role in stem cell differentiation, but the specific functions and mechanisms remain unclear. This study aimed to explore the role of PRMT6 nuclear localization sequence (NLS) in regulating SCAPs osteogenic and odontogenic differentiation and its underlying mechanism.Materials and methodsSCAPs were isolated and identified by flow cytometry. Wild-type PRMT6 and NLS-deleted PRMT6 (PRMT6ΔNLS) overexpression models were constructed via lentiviral infection. Osteogenic and odontogenic differentiation was evaluated via alkaline phosphatase staining, Alizarin Red staining, western blot, and in vivo nude mouse transplantation. Mitochondrial function was analysed by transmission electron microscopy, mitochondrial stress testing, and JC-10 membrane potential assays. Downstream gene expression and β-catenin pathway activity were examined via real-time RT-PCR, western blot, and rescue experiments were performed by exogenous Dickkopf‑1 (DKK1) supplementation.ResultsPRMT6 exhibited nucleocytoplasmic redistribution during early odontogenic differentiation of SCAPs, with increased nuclear export. NLS mutation reduced PRMT6 nuclear accumulation, reversed PRMT6-mediated inhibition of in vitro mineralization and osteogenic and odontogenic marker expression, and promoted in vivo bone-/dentin-like tissue formation. Additionally, PRMT6ΔNLS rescued mitochondrial ultrastructural damage, increased OCR and mitochondrial membrane potential, and improved mitochondrial function. Mechanistically, PRMT6ΔNLS downregulated Wnt antagonist DKK1, activated the β-catenin pathway, and exogenous DKK1 abolished this pro-differentiation effect.ConclusionsPRMT6 nuclear localization is essential for its inhibitory effect on SCAPs osteogenic and odontogenic differentiation. NLS-deleted PRMT6 promotes SCAPs differentiation by rescuing mitochondrial function and activating the β-catenin pathway via downregulating DKK1.Clinical significanceThis study provides a theoretical basis and potential targets for promoting dentin–pulp regeneration by modulating PRMT6 nuclear transport. Introduction Conventional root canal therapy requires removal of infected and necrotic pulp tissue. As a consequence of losing the nutritive, reparative and sensory functions of the dental pulp, treated teeth are prone to longitudinal fracture and eventual extraction.1 Moreover, this approach cannot fundamentally restore the normal physiological and anatomical functions of the dentin–pulp complex. Therefore, regenerative medicine has been introduced into the management of endodontic diseases. As a therapy for periapical diseases of the pulp, dental stem cell–mediated regenerative therapy has become a research hotspot in recent decades, aiming to restore the vitality and function of necrotic and infected pulp and to regenerate a dentin–pulp complex.2,3 During tooth development, histone methylation regulated by histone methyltransferases plays an essential role in the maintenance of stemness, differentiation, apoptosis and tissue regeneration of stem cells.4 As an important component of epigenetic regulation, histone methylation is modulated by protein arginine methyltransferases (PRMTs).5, 6, 7 Among them, protein arginine methyltransferase 6 (PRMT6) undergoes marked changes during the odontogenic differentiation of stem cells.8,9 By regulating the methylation status of histone arginine residues at downstream gene loci, PRMT6 participates in the control of cell proliferation and differentiation, and in the inhibition of cellular senescence and apoptosis in multiple tissues.5,6,10 Previous studies have shown that PRMT6 catalyses asymmetric dimethylation at histone H3R2 (H3R2me2a), which antagonizes trimethylation at H3K4 (H3K4me3) and thereby exerts transcriptional repressive activity.8,9,11 Our previous work further demonstrated that PRMT6 inhibited the migration, chemotaxis and osteogenic and odontogenic differentiation of stem cells from apical papilla (SCAPs) by repressing the expression of downstream target genes, indicating that PRMT6 plays a crucial role in regulating SCAP functions. However, the mechanisms by which PRMT6 modulates SCAP function remain to be fully elucidated. Arginine methylation has been reported to influence the nucleocytoplasmic distribution of proteins either by preventing certain proteins from entering the nucleus or by promoting the nuclear accumulation of others.12 Members of the PRMT family, such as PRMT1 and PRMT3, display high mobility between the nucleus and cytoplasm and shuttle bidirectionally through nuclear translocation.13,14 Signal transduction proteins rely on an intact nuclear transport system. Classical nuclear transport systems (NTS) include the nuclear localization signal (NLS), the carrier importin α/β complex, the nuclear pore complex (NPC), and the Ran protein family that provides energy for transport.15 The NLS required for signal protein transport is a specific amino acid sequence, usually located at the C-terminus, that is recognized by nuclear transport receptors. Through this sequence, signal proteins bind to their transport receptors to form a complex that is guided into or out of the nucleus.16 NLS motifs typically consist of 4 to 8 basic amino acid residues. They impose no strict structural constraints on the linked proteins, and are not cleaved after completion of nuclear translocation. Proteins are recognized by importins via their NLS and are then imported into the nucleus.17 Elucidating the mechanisms of nuclear translocation of signalling proteins is therefore critical for understanding stem cell function. Based on their basic amino acid composition, NLSs are generally classified into classical NLSs, non-classical NLSs, and other types, among which classical NLS–mediated nuclear import is the most common.18 Alterations in the exposure or post-translational modification status of NLS sequences can significantly affect the nuclear translocation of signalling proteins.19, 20, 21 Our previous studies demonstrated that PRMT6 is distributed in both the nucleus and cytoplasm, and that its inhibitory effects occur predominantly in the nucleus.22 Thus, the subcellular localization of PRMT6 is not static but is dynamically regulated by the nuclear transport system.22 Blocking the nuclear translocation of PRMT6 and preventing its nuclear entry may relieve its inhibitory effects on mesenchymal stem cells (MSCs), and this possibility warrants further investigation. Nuclear translocation of proteins is an energy-dependent process in MSCs.23 Moreover, osteogenic and odontogenic differentiation of MSCs is considered a highly energy-demanding, active process.24 As the cellular powerhouse, mitochondria are the major organelles responsible for adenosine triphosphate (ATP) production in MSCs and play a central role in this process. It has been reported that osteogenic differentiation of MSCs is accompanied by a metabolic shift from glycolysis to oxidative phosphorylation, and this mitochondrial metabolic reprogramming is essential to ensure proper progression of differentiation.25 Conversely, impaired MSC function is frequently associated with mitochondrial dysfunction, including reduced mitochondrial membrane potential and increased levels of reactive oxygen species (ROS).26 Against this background, it remains unclear whether inhibition of PRMT6 nuclear transport during MSC differentiation can restore mitochondrial function and energy metabolism and thereby promote osteogenic differentiation. Direct evidence is lacking, and the underlying molecular mechanisms remain to be clarified. Within the regulatory network governing MSC differentiation, the Wnt/β-catenin signalling pathway is recognized as a key positive regulator of osteogenic and odontogenic differentiation. This pathway is crucial for human tooth development; a variety of Wnt signalling components are expressed in odontogenic epithelium and mesenchyme,27 and Wnt10a deficiency leads to enamel hypoplasia and odontopathy in mouse.28 Dickkopf-1 (DKK1) is a classical Wnt pathway antagonist that inhibits Wnt pathway activity by blocking the binding of Wnt ligands to their specific receptors and thereby modulates diverse cellular processes under Wnt control.29 Building on these findings, our previous work showed that downregulation of PRMT6 decreases DKK1 expression, suggesting that nuclear transport of PRMT6 may be a critical step affecting β-catenin pathway activity. Whether inhibition of PRMT6 nuclear transport relieves DKK1-mediated repression, thereby activating the β-catenin signalling pathway and ultimately regulating osteogenic differentiation through effects on mitochondrial function and metabolic reprogramming, constitutes the central question addressed in this study. In the present study, we investigated the function and mechanism of PRMT6 NLS mutation in the osteogenic and odontogenic differentiation of SCAPs. We found that NLS-mutant PRMT6 enhanced mitochondrial function and energy metabolism and thereby promoted SCAP osteogenic and odontogenic differentiation. Furthermore, mechanistic studies indicated that the NLS-mutant PRMT6 activated the β-catenin signalling pathway by downregulating the expression of the downstream antagonist DKK1. These findings provide new insights and candidate targets for dentin regeneration mediated by dental MSCs. Materials and methods Cell culture Experiments using SCAPs were performed in accordance with the ISSCR Guidelines for the Conduct of Human Embryonic Stem Cell Research. Tooth tissue acquisition followed protocols approved by the Ethics Committee of Beijing Stomatological Hospital, Capital Medical University (ethics approval no. CMUSH-IRB-KJ-PJ-2023-49), and written informed consent was obtained from all patients. SCAPs were isolated from ten independent donors who underwent tooth extraction at the Department of Oral and Maxillofacial Surgery, Beijing Stomatological Hospital, Capital Medical University. The donors were 18 to 20 years of age, and the extracted teeth were premolars from orthodontic extractions or impacted third molars, all with incompletely developed roots. Exclusion criteria were: (1) dental developmental anomalies; (2) dental caries or periodontal disease; (3) periapical radiographs showing root development abnormalities or periapical lesions; (4) psychiatric disorders or family history thereof; (5) contraindications for tooth extraction, including myocardial infarction or angina pectoris within the preceding 6 months, systolic blood pressure above 180 mmHg, haemoglobin below 80 g/L, leukaemia, fasting blood glucose above 8.8 mmol/L, pregnancy, hepatitis, or bleeding disorders. Then, SCAPs were isolated and cultured as described previously.30 Then, SCAPs were isolated and cultured as described previously.30 To confirm the mesenchymal stem cell identity of isolated SCAPs, flow cytometry analysis was performed. SCAPs at passage 3 were detached using 0.25% trypsin-EDTA, washed twice with cold phosphate-buffered saline (PBS), and then resuspended in PBS containing 1% bovine serum albumin (BSA) at a density of 1 × 10⁶ cells/mL. Aliquots of 100 µL (1 × 10⁵ cells) were incubated with fluorescein isothiocyanate (FITC)-, phycoerythrin (PE)-, or allophycocyanin (APC)-conjugated monoclonal antibodies against human CD44-FITC(BMS116F, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); CD73-PE (12-0739-42, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); CD90- APC (17-0909-42, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); CD45-APC (47-0459-42, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); CD24-PE (12-0241-82, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); HLA-DR-FIT(11-9952-42, Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50); CD34-APC(47-0349-42-Thermo Fisher Scientific, Waltham, MA, USA; dilution 1:50). Isotype-matched mouse IgG1 antibodies were used as negative controls at the same concentrations. Following incubation for 30 minutes at 4 °C in the dark, the cells were washed twice with PBS, resuspended in 300 µL of PBS, and immediately analysed using a FACSCalibur flow cytometer (BD Biosciences). For each sample, at least 10,000 events were acquired. Data analysis was performed using FlowJo software (version 10, TreeStar). The percentage of positive cells for each marker was calculated based on the isotype control threshold. Representative results are shown in Supplementary Figure 1. Immunofluorescence staining Immunofluorescence staining of SCAPs was performed as described in our previous study.31 Briefly, SCAPs were seeded on circular slides and cultured with osteogenic induction medium. After fixation, washing and permeabilization (for partial cells), the cells were blocked and incubated overnight at 4 °C with primary antibodies against PRMT6 (15395-1-AP, Proteintech, Wuhan, China; dilution 1:200). Following TBST washes, corresponding secondary antibodies (Alexa Fluor594) were added for 2 hours at room temperature in the dark. Finally, slides were mounted with DAPI-containing medium and observed under a fluorescence microscope. Viral infection Lentiviral particles were purchased from GenePharma (Suzhou, China). Complementary DNA encoding human PRMT6 and a PRMT6 NLS-deletion mutant (PRMT6ΔNLS, lacking amino acids 5-12) was subcloned into the LV5 lentiviral vector. Viral infection of SCAPs was performed as described in our previous study.30 Alkaline phosphatase (ALP) staining, Alizarin red staining (ARS) and quantitative calcium analysis SCAPs were cultured in osteogenic induction medium, and ALP activity was assessed using an ALP activity kit (Sigma-Aldrich, St. Louis, MO, USA). ALP activity assays, ARS, and quantitative calcium analysis were performed as previously reported.30 Nuclear and cytoplasmic fractionation Nuclear and cytoplasmic proteins were separated using the NE-PER Nuclear and Cytoplasmic Extraction Reagent Kit (Pierce Biotechnology, Rockford, IL, USA) according to the manufacturer’s instructions and as previously described.22 Histone H3 (H3, bs-0349R, Bioss, Beijing, China; dilution 1:10000) and glyceraldehyde‑3‑phosphate dehydrogenase (GAPDH, 60004-1-Ig, Proteintech, Wuhan, China; dilution 1:1000) were used as loading controls for nuclear and cytoplasmic fractions, respectively. RNA isolation and real-time RT–PCR Total RNA was extracted from SCAPs using TRIzol reagent (Invitrogen, Carlsbad, CA, USA). Equal amounts (2 μg) of RNA were reverse transcribed using oligo (dT) primers and reverse transcriptase according to the manufacturer’s instructions (Invitrogen) to obtain complementary DNA. Real-time RT–PCR was performed as previously described.22 Gene expression changes were calculated using the 2⁻ΔΔCT method. Primer sequences for specific genes are listed in Supplementary Table 1. Western blot and quantitative analysis Cells were lysed in RIPA buffer (10 mmol/L Tris-HCl, 1 mmol/L EDTA, 1% sodium dodecyl sulphate [SDS], 1% NP-40, 1:100 protease inhibitor cocktail, 50 mmol/L β-glycerophosphate, 50 mmol/L sodium fluoride). Proteins were separated on 10% SDS–polyacrylamide gels and transferred onto polyvinylidene difluoride (PVDF) membranes using a semi-dry transfer system (Bio-Rad, Hercules, CA, USA). Membranes were blocked with 5% non-fat milk for 1 hour and incubated with primary antibodies overnight at 4 °C. After washing, membranes were incubated with horseradish peroxidase-conjugated anti-rabbit or anti-mouse IgG (Promega, Madison, WI, USA) and visualized using SuperSignal chemiluminescent reagents (Pierce). The following primary antibodies were used: HA-tag (AE008, Abclonal, Wuhan, China; dilution 1:1000); histone H3 (bs-0349R, Bioss; dilution 1:10000); osteocalcin (OCN; A20800, Abclonal; dilution 1:1000); Dentin Sialophosphoprotein (DSPP; #DF14398, Affinity, OH, America; 1:1000); Runt-related transcription factor 2 (RUNX2; 20700-1-AP, Proteintech; dilution 1:500); bone sialoprotein (BSP; bs-2668R, Bioss; dilution 1:1000); osterix (OSX; bs-11110R, Bioss; dilution 1:1000); bone morphogenetic protein 2 (BMP2; 66383-1-Ig, Proteintech; dilution 1:2000); PRMT6 (15395-1-AP, Proteintech; dilution 1:5000), β-catenin (No. 4695S, Cell Signaling Technology, Danvers, MA, USA; dilution 1:1000); non-phospho (active) β-catenin (Ser33/37/Thr41) (D13A1) (No. 8814, Cell Signaling Technology; dilution 1:1000); Beta Actin (β-actin, #20536-1-AP, Proteintech; dilution 1:5000); as well as GAPDH (60004-1-Ig, Proteintech; dilution 1:10000). All Western blot experiments were repeated as 3 independent biological replicates. Band intensities were quantified using ImageJ software (National Institutes of Health, Bethesda, MD, USA). Target protein levels were normalized to GAPDH or β-actin as the internal control. Chromatin immunoprecipitation (ChIP) assay The assay was performed using the EZ-ChIP kit (Merck Millipore) according to the manufacturer’s protocol. For each ChIP reaction, 2.0 × 10⁶ SCAPs from the indicated groups (Vector, HA‑PRMT6, and PRMT6ΔNLS) were cross‑linked with 1% formaldehyde, and chromatin was sheared by sonication to 200 to 500 bp fragments. Immunoprecipitation was carried out overnight at 4 °C using 4 μg of anti‑H3R2me2a antibody (bs-60146R, Proteintech; dilution 1:100) or normal rabbit IgG as a negative control. After washing, protein‑DNA complexes were eluted, and cross‑linking was reversed. Purified DNA was analysed by qPCR using SYBR Green Master Mix, and enrichment was calculated using the ΔΔCt method normalized to input chromatin. The real‑time PCR primers targeted the DKK1 promoter region. These sequences were as follows: forward, 5′‑GGCTTTGTTGTCTCCCTCCCAAG‑3′; reverse, 5′‑CCACCGCGGCTGCCTTTATA‑3′. Nude mouse transplantation, haematoxylin and eosin (H&E), Masson’s trichrome and immunohistochemical staining All animal procedures were reviewed and approved by the Animal Welfare Ethics Committee of Beijing MDKN Biotechnology Co., LTD. (Approval number: MDKN-2024-126)., and were conducted in strict accordance with the experimental animal care and use guidelines of Beijing Animal Control Committee. Twelve female immunocompromised BALB/c-nu mice (8 weeks old, 16-18 g) were purchased from Vital River Co., Ltd. (Beijing, China). Mice were maintained under specific pathogen-free conditions with free access to food and water. A total of 3 experimental groups were established: (1) control group (hydroxyapatite/tricalcium phosphate (HA/TCP) + Vector cells), (2) HA-PRMT6 group (HA/TCP + wild-type PRMT6 cells), and (3) PRMT6ΔNLS group (HA/TCP + PRMT6 NLS-mutant cells). Each mouse received 2 transplants on both sides of the dorsal region. The assignment of treatment groups to the left and right sides of each mouse was randomized using a computer‑generated allocation sequence, ensuring balanced representation of each treatment group across sides. A total of 24 transplant sites were generated, with n = 8 biologically independent transplant sites per group. For transplantation, mixtures containing approximately 4.0 × 10⁶ cells and 40 mg HA/TCP ceramic particles (Engineering Research Center for Biomaterials, Sichuan University, China) were incubated at 37 °C for 1 hour and then transplanted subcutaneously into the designated dorsal region of the mice. All procedures were performed in accordance with the approved animal protocol. Transplants were harvested 8 weeks post-surgery, fixed in 10% formalin, decalcified in buffered 10% EDTA (pH 8.0), and embedded in paraffin. Sections were deparaffinized, rehydrated, and stained with H&E and Masson’s trichrome. Subsequently, paraffin-embedded samples were sectioned at 5 μm. H&E and Masson’s trichrome staining were used for structural analysis, and immunohistochemical staining was performed as previously described.32 For immunohistochemistry, sections were deparaffinized, rehydrated, and subjected to antigen retrieval by microwave heating in 0.01 M sodium citrate buffer (pH 6.0) for 10 to 15 minutes. Endogenous peroxidase was blocked with 3% H₂O₂ in methanol for 30 minutes, and non-specific binding was blocked with 5% normal goat serum for 1 hour at room temperature. Sections were incubated overnight at 4 °C with primary antibodies against DSPP (rabbit polyclonal, bs-10316R, Bioss; 1:200), RUNX2 (rabbit polyclonal, bs-20003R, Bioss; 1:200), and OCN (rabbit polyclonal, bs-4917R, Bioss; 1:200). Negative controls were incubated with normal rabbit IgG (Bioss) instead of primary antibody. After washing, sections were incubated with HRP-conjugated goat anti-rabbit IgG secondary antibody (bs-0295G-HRP, Bioss; 1:300) for 2 hours at room temperature. Antibody binding was visualized using a DAB substrate kit, and sections were counterstained with haematoxylin. Images were captured using a light microscope (Olympus BX53), and 5 fields per section were randomly selected for quantitative analysis using ImageJ software (NIH, USA).32 Semi-quantitative analysis of the immunohistochemical staining results was performed using ImageJ. Transmission electron microscopy (TEM) of mitochondria SCAPs were fixed in an electron microscopy fixative for 2 to 4 hours at 4 °C to preserve cellular ultrastructure. The samples were then dehydrated through a graded ethanol series (30%, 50%, 70%, 90%, and 100%; 10-15 minutes each) and infiltrated with epoxy resin using progressively increasing resin-to-ethanol ratios (3:1, 1:1, and 1:3; 1 hour for each step). Subsequently, the specimens were embedded in pure resin and polymerized at 60 °C for 48 hours. Ultrathin sections (60-90 nm) were prepared with an ultramicrotome, collected on copper grids, and stained with 2% uranyl acetate for 15 minutes followed by lead citrate for 5 minutes to enhance visualization of mitochondrial membranes and cristae. The grids were examined using a TEM operated at 60 to 120 kV. Low-magnification images were first obtained to identify regions of interest, followed by high-magnification imaging to assess mitochondrial cristae morphology, matrix density, and overall organelle architecture. Digital micrographs were acquired and analysed using dedicated TEM software to quantify mitochondrial dimensions, evaluate cristae integrity, and compare ultrastructural characteristics across experimental groups. Three independent samples per group (n = 3) were randomly selected. Quantification metrics the total number of mitochondria per cell were measured using ImageJ. All image acquisition and quantitative analyses were performed by an investigator blinded to the group assignments to minimize observer bias. Oxygen consumption rate The oxygen consumption rate was measured in real time using the Seahorse XF Cell Mito Stress Test on an XF-24 Extracellular Flux Analyzer (Agilent, Santa Clara, CA, USA), as described previously.24 Briefly, prior to the experiment, the Seahorse XFe24 Analyzer was powered on and the Wave software (Agilent) was allowed to run overnight for instrument stabilization. A 24‑well utility plate was prepared with 1 mL of calibration solution per well, and the XFe24 sensor cartridge was immersed overnight to ensure proper sensor hydration. SCAPs were seeded in the XF‑24 cell culture plate at a density of 8 × 10⁴ cells per well prior to the assay. On the day of measurement, the culture medium was exchanged for Seahorse XF DMEM, and cells were pre‑incubated for 45 minutes at 37 °C in a non‑CO₂ incubator. The Mito Stress Test Kit (Agilent) was used to prepare the following compounds for sequential injection: oligomycin at a final concentration of 1.5 μM, fluoro‑carbonyl cyanide phenylhydrazone (FCCP) at a final concentration of 1.0 μM, and a mixture of rotenone and antimycin A at final concentrations of 1.0 μM each. Following baseline recordings, these compounds were injected sequentially, and oxygen consumption rates were measured after each injection. Each measurement cycle consisted of 3 recordings with an interval of 8 minutes, and the total duration of the mitochondrial stress test was approximately 100 minutes. After the assay, cells were lysed and protein concentration was determined using a bicinchoninic acid (BCA) protein assay kit. OCR values were normalized to total protein content per well. Wells with evidence of cell detachment, air bubbles, or baseline OCR values deviating beyond 2 standard deviations from the group mean were excluded from analysis. Each experimental group contained at least 3 technical replicate wells. The assay was independently performed 3 times (n = 3 biological replicates) align with established standards for Mito Stress Test reporting and ensure reproducibility. Mitochondrial membrane potential (ΔΨm) assay Mitochondrial membrane potential (ΔΨm) in SCAPs was assessed using the JC-10 assay kit (Solarbio, Beijing, China) according to the manufacturer’s instructions and as reported in our previous study.24 Statistical analysis All statistical analyses were performed using SPSS 10.0 software (IBM Corp., Armonk, NY, USA). Differences between 2 groups were evaluated using Student’s t-test, and comparisons among multiple groups were performed using one-way analysis of variance (ANOVA). All tests were two-tailed with α = 0.05. Prior to parametric analyses, normality was verified by the Shapiro-Wilk test and homogeneity of variances by Levene’s test, and all data met the assumptions. For one-way ANOVA, Tukey’s HSD test was used for post-hoc comparisons, while for time-course data, two-way ANOVA was applied to assess the main effects of group and time as well as their interaction, followed by post-hoc comparisons with Sidak correction. Effect sizes for ANOVA are reported as partial η² with 95% confidence intervals, and for group comparisons, mean differences with 95% CIs are provided. In this study, n refers to biologically independent donors rather than technical replicates. For in vitro experiments, each independent experiment was performed using cells derived from separate donors or separate cell passages, with each condition tested in triplicate technical wells. P value ≤ .05 was considered statistically significant. Results PRMT6 subcellular localization changed during osteogenic differentiation of SCAPs, and nuclear import of PRMT6 depends on its NLS domain To investigate the effect of NLS mutation on PRMT6 subcellular localization in SCAPs, we first predicted the NLS of PRMT6 using bioinformatic tools, and candidate NLS sequences were obtained. SCAPs were then isolated in vitro and characterized by flow cytometry with fluorescence-conjugated antibodies against CD90, CD44, CD29, STRO-1, CD24, CD34 and CD45, confirming their identity as SCAPs (Supplementary Figure 1). Immunofluorescence staining was performed at days 0, 1, 2 and 3 of osteogenic induction in the wild-type group (Figure 1A). During osteogenic differentiation of SCAPs, PRMT6 progressively exited the nucleus, with decreased nuclear PRMT6 levels and increased cytoplasmic PRMT6 levels. SCAPs were transduced with lentivirus to generate a PRMT6 NLS-mutant group (PRMT6ΔNLS group), a wild-type PRMT6 group (HA-PRMT6 group) and a control vector group (Vector group). Western blot showed comparable overexpression efficiency of wild-type PRMT6 and NLS-mutant PRMT6 (Figure 1B). Densitometric quantification confirmed no statistically significant difference between the 2 groups (Figure 1C).Fig. 1Mutation of PRMT6 nuclear localization signal inhibited its nuclear translocation in SCAPs. (A) Immunofluorescence staining of SCAPs after osteogenic induction. Scale bar: 100 µm. (B) Western blot results showing the overexpression efficiency of HA-PRMT6 and the mutation efficiency of PRMT6∆NLS in SCAPs. (C) Quantification of Western blot bands for HA. (D-E) Western blot analysis showing the effect of NLS mutation on the nuclear (D)-cytoplasmic (E) shuttling of exogenous PRMT6. Histone H3 (H3) served as nuclear internal control, and GAPDH served as the cytoplasm internal control. (F-G) Quantification of Western blot bands for HA in nuclear (F) and cytoplasmic (G). (H) Schematic diagram illustrating the mechanism by which PRMT6 nuclear localization signal mutation inhibits its nuclear translocation. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3).Fig 1 dummy alt text Mutation of PRMT6 nuclear localization signal inhibited its nuclear translocation in SCAPs. (A) Immunofluorescence staining of SCAPs after osteogenic induction. Scale bar: 100 µm. (B) Western blot results showing the overexpression efficiency of HA-PRMT6 and the mutation efficiency of PRMT6∆NLS in SCAPs. (C) Quantification of Western blot bands for HA. (D-E) Western blot analysis showing the effect of NLS mutation on the nuclear (D)-cytoplasmic (E) shuttling of exogenous PRMT6. Histone H3 (H3) served as nuclear internal control, and GAPDH served as the cytoplasm internal control. (F-G) Quantification of Western blot bands for HA in nuclear (F) and cytoplasmic (G). (H) Schematic diagram illustrating the mechanism by which PRMT6 nuclear localization signal mutation inhibits its nuclear translocation. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3). Nuclear and cytoplasmic proteins were then extracted from SCAPs in the Vector, HA-PRMT6, and PRMT6ΔNLS groups. The intracellular distribution of HA-PRMT6 was evaluated by Western blot to determine the impact of NLS mutation on nuclear import and export of exogenous PRMT6. NLS mutation decreased the nuclear fraction and increased the cytoplasmic fraction of PRMT6, demonstrating that mutation of the NLS significantly reduced nuclear accumulation of PRMT6 (Figure 1 D-E). Quantitative analysis of Western blot bands corroborated these visual observations (Figure 1 F-G). PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vitro To further clarify the effect of PRMT6 NLS mutation on the osteogenic and odontogenic differentiation potential of SCAPs in vitro, SCAPs were cultured under osteogenic and odontogenic induction conditions. ALP activity and ALP staining were performed after 5 days of induction, whereas ARS and measurement of calcium content were carried out at 1 and 2 weeks. After 2 weeks of induction, cell lysates were analysed by Western blot to assess the protein levels of osteogenic markers BSP, OCN, RUNX2, BMP2 and OSX, and odontogenic marker DSPP. After 5 days of osteogenic and odontogenic induction, ALP activity assays showed that PRMT6 overexpression decreased ALP activity compared with the Vector group, whereas PRMT6 NLS mutation rescued this reduction in ALP activity (Figure 2A, and B). Consistently, Alizarin Red staining and quantitative calcium analysis demonstrated that PRMT6 overexpression impaired mineralization of SCAPs at both 1 and 2 weeks, and PRMT6 NLS mutation restored this impaired mineralization (Figure 2C, and D). Moreover, Western blot and quantitative analysis revealed that, relative to the HA-PRMT6 group, the PRMT6ΔNLS group exhibited significantly increased expression of BSP, OCN, RUNX2, BMP2, OSX, and DSPP (Figure 2E, and F).Fig. 2PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vitro. (A) ALP activity assay of PRMT6-overexpressing SCAPs and PRMT6-mutant SCAPs. (B) Quantitative analysis of ALP activity. (C) Alizarin red staining. (D) Quantitative analysis of calcium deposition in 1 week and 2 week. (E) Western blot detection of BSP, OCN, RUNX2, BMP2, OSX, and DSPP expression. GAPDH served as an internal control. (F) Quantitative analysis of western blot bands for BSP, OCN, RUNX2, BMP2, OSX, and DSPP. Statistical significance was assessed using a one-way or two-way ANOVA, and all error bars represent SD (n = 3).Fig 2 dummy alt text PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vitro. (A) ALP activity assay of PRMT6-overexpressing SCAPs and PRMT6-mutant SCAPs. (B) Quantitative analysis of ALP activity. (C) Alizarin red staining. (D) Quantitative analysis of calcium deposition in 1 week and 2 week. (E) Western blot detection of BSP, OCN, RUNX2, BMP2, OSX, and DSPP expression. GAPDH served as an internal control. (F) Quantitative analysis of western blot bands for BSP, OCN, RUNX2, BMP2, OSX, and DSPP. Statistical significance was assessed using a one-way or two-way ANOVA, and all error bars represent SD (n = 3). PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vivo To evaluate the impact of PRMT6 NLS mutation on the osteogenic and odontogenic differentiation capacity of SCAPs in vivo, mixtures of SCAPs and HA/TCP particles were transplanted into the dorsal subcutaneous region of nude mice (Figure 3A). Eight weeks later, the mice were sacrificed and the grafts were harvested for Masson’s trichrome staining, and immunohistochemical detection of DSPP, OCN and RUNX2. Masson’s staining and quantitative analysis showed that, compared with the control group, the HA-PRMT6 group formed less bone-like tissue. In contrast, the NLS mutation led to more extensive regeneration of bone- and dentin-like tissues (Figure 3B, and D). Furthermore, immunohistochemical staining and quantitative analysis demonstrated that DSPP, RUNX2 and OCN expression were markedly reduced in the HA-PRMT6 group compared with the control group, whereas PRMT6ΔNLS restored the decreased expression of DSPP, RUNX2 and OCN in SCAPs (Figure 3C, E-G).Fig. 3PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vivo. (A) Schematic diagram of subcutaneous transplantation of SCAPs/HA/TCP composites into the dorsal region of nude mice. (B) Masson trichrome staining images. (C) Immunohistochemical staining micrographs to visualize distribution of DSPP, RUNX2 and OCN. (D) Quantitative analysis of Masson trichrome staining. (E-G) Quantitative analysis of DSPP, RUNX2 and OCN staining results. Original magnification: 200 × . Scale bar = 100 μm. HA, HA-TCP replanted on the back of the nude mouse; CT, the newly formed connective tissue; B, the bone-like tissue. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 8).Fig 3 dummy alt text PRMT6ΔNLS enhanced the osteogenic and odontogenic differentiation of SCAPs in vivo. (A) Schematic diagram of subcutaneous transplantation of SCAPs/HA/TCP composites into the dorsal region of nude mice. (B) Masson trichrome staining images. (C) Immunohistochemical staining micrographs to visualize distribution of DSPP, RUNX2 and OCN. (D) Quantitative analysis of Masson trichrome staining. (E-G) Quantitative analysis of DSPP, RUNX2 and OCN staining results. Original magnification: 200 × . Scale bar = 100 μm. HA, HA-TCP replanted on the back of the nude mouse; CT, the newly formed connective tissue; B, the bone-like tissue. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 8). PRMT6ΔNLS restored mitochondrial function and energy metabolism in SCAPs Next, to determine whether PRMT6 NLS mutation modulates osteogenic and odontogenic differentiation of SCAPs by affecting mitochondrial function, we further examined mitochondrial ultrastructure and bioenergetics. TEM analysis revealed that PRMT6 overexpression induced marked mitochondrial swelling, mainly characterized by matrix swelling and cristae swelling, along with shortened, disrupted or even lost cristae and the formation of vacuole-like structures (Figure 4A). Concomitantly, quantitative analysis revealed that mitochondrial number was significantly reduced in the HA‑PRMT6 group, but significantly increased in the PRMT6ΔNLS group relative to the HA‑PRMT6 group (Figure 4B). Consistent with these structural changes, Seahorse mitochondrial stress tests showed that the oxygen consumption rate (OCR)—including basal OCR, ATP production, maximal respiration, spare respiratory capacity, proton leak and non-mitochondrial OCR—was reduced in the HA-PRMT6 group, whereas PRMT6 NLS mutation largely rescued these decreases in OCR (Figure 4C-I).Fig. 4PRMT6ΔNLS restored mitochondrial function and energy metabolism in SCAPs. (A) TEM images of mitochondria. (B) Quantification number of mitochondria of single cell analysis. (C-I) Effects of HA-PRMT6 and PRMT6∆NLS on the oxygen consumption rate (OCR) in SCAPs. The Seahorse XFe24 analyser showed the results of OCR curves (C), the basal OCR (D), ATP production (E), maximal respiration (F), spare respiratory capacity (G), proton leak (H) and non-mitochondrial oxygen consumption (I). (J) JC-10 assay results. Scale bar: 50 µm. (K) Schematic illustration showing that PRMT6 nuclear localization signal mutation promotes mitochondrial energy metabolism and morphological recovery. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3).Fig 4 dummy alt text PRMT6ΔNLS restored mitochondrial function and energy metabolism in SCAPs. (A) TEM images of mitochondria. (B) Quantification number of mitochondria of single cell analysis. (C-I) Effects of HA-PRMT6 and PRMT6∆NLS on the oxygen consumption rate (OCR) in SCAPs. The Seahorse XFe24 analyser showed the results of OCR curves (C), the basal OCR (D), ATP production (E), maximal respiration (F), spare respiratory capacity (G), proton leak (H) and non-mitochondrial oxygen consumption (I). (J) JC-10 assay results. Scale bar: 50 µm. (K) Schematic illustration showing that PRMT6 nuclear localization signal mutation promotes mitochondrial energy metabolism and morphological recovery. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3). In addition, mitochondrial membrane potential in SCAPs was assessed using the JC-10 assay. As shown in Figure 4J, JC-10 staining showed a decreased red fluorescence ratio in HA-PRMT6 SCAPs, indicating a loss of mitochondrial membrane potential, whereas PRMT6ΔNLS partially restored the red aggregate signal compared with HA-PRMT6 cells. Together, these findings suggest that PRMT6ΔNLS mitigates PRMT6-induced mitochondrial dysfunction and restores mitochondrial energy metabolism in SCAPs (Figure 4K). PRMT6ΔNLS activated the β-catenin signalling pathway in SCAPs According to our previous gene chip analysis, knockdown of PRMT6 altered the expression of several downstream genes, including glutathione peroxidase 3 (GPX3), C‑X‑C motif chemokine ligand 12 (CXCL12), insulin‑like growth factor binding protein 5 (IGFBP5) and DKK1, with upregulation of GPX3, CXCL12 and IGFBP5 and downregulation of DKK1.22 To investigate whether PRMT6ΔNLS in SCAPs also affects these genes, real-time RT–PCR was performed. PRMT6ΔNLS SCAPs exhibited altered expression of GPX3, CXCL12, IGFBP5 and DKK1, showing a pattern consistent with our previous observations after PRMT6 knockdown (Figure 5A-D). To directly assess whether the methyltransferase activity of PRMT6 toward its target chromatin locus depends on its nuclear localization, we performed ChIP assays to detect H3R2me2a at the DKK1 promoter in SCAPs. This modification is a characteristic repressive histone mark generated by PRMT6. As shown in Figure 5E, HA-PRMT6 overexpression led to a significant increase in H3R2me2a enrichment at the DKK1 promoter compared with the Vector control group. In contrast, PRMT6ΔNLS overexpression did not result in any significant elevation of H3R2me2a levels. These results demonstrate that nuclear localization of PRMT6 is required for its catalytic activity toward H3R2 at the DKK1 promoter. Deletion of the NLS abrogates the ability of PRMT6 to deposit this repressive mark even though the methyltransferase domain remains intact. As a well-characterized Wnt inhibitor and key component of the Wnt/β-catenin signalling pathway, changes in DKK1 expression can modulate β-catenin signalling activity.33 In this study, Western blot and quantitative analysis were used to detect total β-catenin and active β-catenin levels (Figure 5F-G). Compared with the control group, total β-catenin and active β-catenin expression were decreased in the HA-PRMT6 group, whereas PRMT6ΔNLS reversed the PRMT6-induced reduction in total and active β-catenin.Fig. 5PRMT6ΔNLS activated the Wnt/β-catenin signalling pathway in SCAPs. (A-D) Real-time RT-PCR results for the expression levels of GPX3, CXCL12, IGFBP5, and DKK1. (E) The ChIP assay results for the level of H3R2me2a in DKK1 promoter. (F) Expression levels of Active-β-catenin and total β-catenin detected by western blot. GAPDH served as an internal control. (G) Quantitative analysis of western blot bands for Active-β-catenin and total β-catenin. (H) ALP staining and Alizarin red staining. (I) Quantitative analysis of ALP activity. (J) Quantitative analysis of calcium deposition. (K) Schematic diagram illustrating that PRMT6 nuclear localization signal mutation promotes osteogenic and odontogenic differentiation by downregulating DKK1 and activating the β-catenin signalling pathway. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3).Fig 5 dummy alt text PRMT6ΔNLS activated the Wnt/β-catenin signalling pathway in SCAPs. (A-D) Real-time RT-PCR results for the expression levels of GPX3, CXCL12, IGFBP5, and DKK1. (E) The ChIP assay results for the level of H3R2me2a in DKK1 promoter. (F) Expression levels of Active-β-catenin and total β-catenin detected by western blot. GAPDH served as an internal control. (G) Quantitative analysis of western blot bands for Active-β-catenin and total β-catenin. (H) ALP staining and Alizarin red staining. (I) Quantitative analysis of ALP activity. (J) Quantitative analysis of calcium deposition. (K) Schematic diagram illustrating that PRMT6 nuclear localization signal mutation promotes osteogenic and odontogenic differentiation by downregulating DKK1 and activating the β-catenin signalling pathway. Statistical significance was assessed using a one-way ANOVA, and all error bars represent SD (n = 3). PRMT6ΔNLS enhanced osteogenic differentiation of SCAPs by activating the β-catenin signalling pathway We next examined whether the enhanced osteogenic differentiation mediated by PRMT6 NLS mutation was dependent on the β-catenin signalling pathway. DKK1 was added during osteogenic induction. After 5 days, ALP staining and quantitative analysis showed that DKK1 treatment attenuated the PRMT6ΔNLS-induced increase in ALP activity (Figure 5H, and I). Similarly, Alizarin Red staining and calcium quantification at 2 weeks demonstrated that DKK1 treatment reduced the enhanced in vitro mineralization capacity of SCAPs conferred by PRMT6ΔNLS (Figure 5H, and J). These results indicate that PRMT6ΔNLS promotes osteogenic differentiation of SCAPs at least in part by activating the β-catenin signalling pathway (Figure 5J). Discussion The success of pulp regeneration therapy critically depends on controlling the osteogenic and odontogenic differentiation of dental-derived stem cells, in which epigenetic regulation plays a central role. PRMT6 participates in regulating cell proliferation and differentiation and in suppressing cellular senescence and apoptosis in various tissues by modulating the methylation status of arginine residues at downstream genomic loci.5,6,34 PRMT6 has been reported to be closely associated with the osteogenic differentiation of bone marrow-derived stem cells.6 In this context, the present study focused on PRMT6 and explored how its NLS domain governs the osteogenic and odontogenic differentiation of SCAPs. Nucleocytoplasmic shuttling of signalling proteins is a key component of nuclear–cytoplasmic information exchange. Its functions and mechanisms are highly diverse, influencing not only DNA replication and transcription but also many critical processes such as directed differentiation of stem cells.35 Here, we show for the first time that PRMT6 undergoes marked subcellular redistribution during the early phase of osteogenic and odontogenic differentiation of SCAPs, with a time-dependent increase in its cytoplasmic fraction. This dynamic behaviour indicates that PRMT6 nucleocytoplasmic shuttling is not a static phenomenon but an active process tightly coupled to its regulatory functions. Given our previous findings that PRMT6 exerts inhibitory effects on SCAP differentiation primarily within the nucleus, we hypothesized that, at the onset of differentiation, cells may actively export PRMT6 from the nucleus to relieve transcriptional repression of osteogenic and odontogenic genes and thereby initiate the differentiation program. This hypothesis is mechanistically supported by our earlier work, in which we identified LMNA, a major nuclear lamina component, as a direct binding partner of PRMT6 in SCAPs.22 Importantly, knockdown of LMNA significantly increased nuclear accumulation of PRMT6 while decreasing its cytoplasmic fraction, indicating that LMNA functions as a nuclear-retention factor for PRMT6. Therefore, during early osteogenic and odontogenic differentiation, reduced LMNA binding—potentially due to post-translational modifications of either protein or changes in LMNA expression/localization—may permit PRMT6 to exit the nucleus. This active export would then relieve PRMT6-mediated transcriptional repression of differentiation-related genes, allowing the differentiation program to proceed. This phenomenon is consistent with studies of other PRMT family members, such as PRMT1 and PRMT5, which finely tune cellular functions through regulated nucleocytoplasmic shuttling.36,37 Thus, we speculated that preventing nuclear entry of PRMT6 might abolish its inhibitory effects on osteogenic and odontogenic differentiation in SCAPs. To directly test the hypothesis that nuclear localization is required for the inhibitory function of PRMT6, we precisely interfered with its nuclear import based on core principles of the NTS. Nuclear translocation of signalling proteins is mediated by the coordinated action of NLS motifs, nuclear transport receptors (importin α/β), the NPC and the Ran GTPase system.38,39 Modifying the NLS is one of the most effective strategies to regulate nuclear import, as this sequence is necessary for importin α/β-mediated classical nuclear transport.40 In the process of protein nuclear translocation, the NLS plays a decisive role; proteins enter and exit the nucleus by binding transport receptors via this sequence.41 Although NLS motifs can be predicted by software, experimental validation is essential.42 Through bioinformatic prediction combined with experimental verification, we identified a basic amino acid-rich region in the C-terminus of PRMT6 as its critical NLS, consistent with the characteristics of classical NLSs described by Kurz et al.43 The NLS-deletion mutant (NLS-mut) we subsequently constructed displayed markedly reduced nuclear accumulation in nuclear–cytoplasmic fractionation assays, confirming the essential role of this sequence in PRMT6 nuclear import. Aberrant nuclear translocation can profoundly affect stem cell differentiation.44,45 For example, overexpression of the nuclear transport receptor IPO7 has been shown to regulate the balance of osteogenic and odontogenic differentiation by promoting nuclear import of RUNX2, underscoring the importance of the nuclear transport system in determining the fate of dental-derived stem cells.44 In our study, in vitro osteogenic induction of SCAPs revealed that, consistent with our previous work, PRMT6 overexpression inhibited osteogenic differentiation. By contrast, NLS mutation reversed all inhibitory phenotypes associated with PRMT6 overexpression, including reduced early ALP activity, diminished late-stage mineralization, and downregulation of key osteogenic and odontogenic markers (BSP, OCN, RUNX2, BMP2 and OSX). Importantly, in a nude mouse transplantation model, PRMT6ΔNLS, compared with nuclear PRMT6, supported the formation of more abundant and mature bone-/dentin-like tissues, accompanied by higher levels of RUNX2, DSPP and OCN deposition. Together, these in vitro and in vivo data strongly indicate that the inhibitory effect of PRMT6 on SCAP differentiation is strictly dependent on its nuclear localization, and that blocking its nuclear import is sufficient to relieve repression and promote osteogenic and odontogenic differentiation of SCAPs. Numerous studies have demonstrated that members of the PRMT family play important roles in stem cell metabolism. Yang et al46 reported that PRMT5 maintains the stemness of intestinal stem cells by inhibiting the expression of histone deacetylase 9, thereby sustaining high levels of H3K27ac. This regulation supports ISC self-renewal and suppresses apoptosis. Meanwhile, PRMT family members such as PRMT1, PRMT6, and PRMT7 have also been shown to significantly affect neural stem cell metabolism by inhibiting neuronal differentiation.47 Furthermore, Wang et al48 demonstrated that PRMT1 maintains DNA repair and genomic stability via methylation of MRE11, exerting a tumour suppressor-like protective role in hematopoietic stem cells/leukaemia stem cells. Under conditions of energy deficiency, however, the methyltransferase activity of PRMT1 is suppressed, leading to defective DNA repair and genomic instability, which in turn drives the malignant evolution of acute myeloid leukaemia stem cells. In summary, PRMT family members regulate stem cell metabolism through diverse mechanisms including modulation of histone modifications, cell differentiation, and DNA repair. These mechanisms play essential roles in maintaining stemness, regulating differentiation, and influencing genomic stability across distinct tissue-derived stem cells. At the mechanistic level, we linked nuclear PRMT6 activity to cellular energy metabolism. We found that elevated PRMT6 causes severe mitochondrial ultrastructural damage in SCAPs, reduced OCR, and decreased mitochondrial membrane potential, whereas PRMT6ΔNLS significantly rescued these defects. These findings suggest that PRMT6, acting in the nucleus, may indirectly impair mitochondrial function through transcriptional regulation. Interestingly, previous study revealed that PRMT6 directly methylates sirtuin 7 (SIRT7) at arginine 388, which suppresses the H3K18 deacetylase activity of SIRT7 and epigenetically regulates mitochondria biogenesis. This raises the possibility that PRMT6 also modulates mitochondrial function through key biogenesis regulators such as SIRT7.49 Consistently, our TEM analysis revealed an increased number of mitochondria in SCAPs following PRMT6ΔNLS expression, suggesting that PRMT6ΔNLS may promote mitochondrial biogenesis, although this possibility requires further investigation. When PRMT6 is retained in the cytoplasm, its aberrant repression of mitochondrial-related genes is likely alleviated, thereby providing the energetic basis required for SCAP differentiation. We then asked through which signalling pathway nuclear PRMT6 executes its inhibitory function. Building on our previous gene chip data, we focused on the Wnt/β-catenin signalling pathway—a central regulator in tooth development and bone homeostasis that extensively crosstalks with cellular metabolism—and identified the classical Wnt antagonist DKK1 as a potential downstream target of PRMT6.50,51 Studies have shown that overexpression of DKK1 inhibits Wnt/β-catenin signalling in dental epithelium and prevents the formation of normal tooth morphology during early or late stages of mouse tooth germ development, indicating that DKK1 and Wnt/β-catenin signalling are crucial for human tooth development.52 Our experiments demonstrated that PRMT6ΔNLS significantly reduced DKK1 expression at the mRNA level. To verify whether this regulation depends on the methyltransferase activity and nuclear localization of PRMT6, we examined the levels of H3R2me2a at the DKK1 promoter, a characteristic repressive histone mark generated by PRMT6. The results showed that wild‑type PRMT6 overexpression significantly enhanced H3R2me2a enrichment, whereas PRMT6ΔNLS did not, indicating that nuclear localization is a prerequisite for PRMT6 to exert its methyltransferase activity on target chromatin loci in vivo. Accordingly, by reducing DKK1 expression, PRMT6ΔNLS relieved PRMT6‑mediated suppression of β‑catenin signalling, which resulted in accumulation of total and non‑phosphorylated active β‑catenin protein and effective activation of the pathway. Moreover, exogenous DKK1 supplementation reversed the promotive effects of NLS mutation on osteogenic and odontogenic differentiation of SCAPs. This is in line with the findings of Florio et al, who reported that inhibiting DKK1 expression promotes fracture healing and new bone formation in primates by enhancing β-catenin signaling.53 Regarding the significant reduction in total β-catenin levels upon PRMT6 overexpression, we propose that this phenomenon can be understood in the context of a DKK1‑mediated mechanism when considered together with the unique cellular properties of SCAPs.54 As mesenchymal-derived stem cells, SCAPs exhibit low E-cadherin expression and maintain high basal Wnt/β-catenin activity to preserve their stemness and odontogenic/osteogenic differentiation potential.55,56 Consequently, the majority of total β-catenin in SCAPs exists as the cytosolic signal pool rather than the membrane-anchored pool. Upon PRMT6‑mediated upregulation of DKK1 and subsequent Wnt blockade, the destruction complex may become hyperactive and accelerate the degradation of the abundant cytosolic β‑catenin pool.57,58 Furthermore, membrane‑associated β‑catenin relies on continuous replenishment from the cytosol. After prolonged Wnt blockade, failure of re‑supply may lead to progressive depletion of the membrane pool, and these factors together could contribute to a marked drop in total protein levels. Consistently, our rescue experiments using exogenous DKK1 partially reversed the pro‑differentiation effect of PRMT6ΔNLS, indirectly supporting this interpretation. Thus, the observed decline in total β‑catenin appears compatible with a DKK1‑mediated mechanism and may reflect the specific Wnt/β‑catenin signalling dynamics in SCAPs.59 Several limitations of this study should be acknowledged. First, although SCAPs represent a relevant cell model for dentin–pulp regeneration, the findings reported here are derived from a single stem cell type. Whether PRMT6 nuclear localization similarly regulates odontogenic differentiation in other dental or mesenchymal stem cell populations remains to be investigated. Second, the in vivo experiments were performed using an ectopic subcutaneous transplantation model in immunocompromised mice, which does not fully recapitulate the native pulp microenvironment, including the complex inflammatory and immune responses that occur during pulp regeneration. Future studies using orthotopic models such as tooth slice or root fragment implantation will be necessary to validate the translational potential of modulating PRMT6 nuclear transport. Third, in addition to the Wnt/β-catenin pathway, other signalling cascades have also been implicated in the osteogenic differentiation of dental stem cells. For instance, a very recent study demonstrated that Calpain-1 promotes periodontal ligament stem cell osteogenesis and periodontal regeneration via the PHLPP1-ERK axis.60 Whether PRMT6 cross-talks with other pathways during SCAP differentiation remains an open question. Fourth, epigenetic regulators have been shown to participate in inflammatory dental tissue destruction. Previous study has found that HDAC9‑mediated pyroptosis promotes orthodontically induced inflammatory root resorption.61 While our current study focuses on the physiological role of PRMT6 in odontogenic differentiation, it is conceivable that under inflammatory or mechanical stress conditions, PRMT6 nuclear transport and its downstream effects on mitochondrial function and β‑catenin signalling might also contribute to pulp pathology or regeneration failure. This possibility warrants further investigation using appropriate in vivo disease models. Addressing these limitations in future studies will help to establish the broader applicability and mechanistic depth of PRMT6‑targeted strategies for dentin–pulp regeneration. Collectively, our data outline a coherent signalling axis whereby mutation of the PRMT6 NLS blocks its nuclear import, promotes restoration of mitochondrial function, downregulates DKK1, releases inhibition of the β-catenin pathway, and ultimately enhances the osteogenic and odontogenic differentiation of SCAPs. Conclusion In conclusion, this study systematically demonstrates that nuclear transport of PRMT6 acts as a central negative regulator of osteogenic and odontogenic differentiation in SCAPs. We show that targeted interference with the NLS allows precise control of PRMT6 subcellular localization and thereby alters its function. We further elucidate a novel molecular mechanism whereby nuclear PRMT6 suppresses DKK1 expression, inhibits β-catenin signalling and impairs mitochondrial function, while inhibition of PRMT6 nuclear import reverses these effects. These findings not only deepen our understanding of how epigenetic regulators control stem cell fate through subcellular localization of proteins, but also validate nuclear translocation of signalling proteins as an effective target for modulating stem cell function. Our work provides a solid theoretical basis and promising molecular targets for developing novel regenerative strategies that promote dentin–pulp complex regeneration by manipulating nuclear transport. Author contributions W.Y.: design and conception, collection and assembly of data, data analysis, search of literature, manuscript writing, financial support, and creation of figure and table. X.G. and B.Z.: search of literature, collection and assembly of data, data analysis, manuscript writing, and creation of figure and table. Y.L.: collection and assembly of data, and data analysis. Z.S.: creation of figure and table. C.Z. and R.S.: design and conception, manuscript revising, financial support, and final approval of the manuscript. All authors have read and agreed to the published version of the manuscript. Institutional review board The study was conducted in accordance with the Declaration of Helsinki and approved by the ethics guideline of Ethics Committee of Beijing Stomatology Hospital (Approval number: CMUSH-IRB-KJ-PJ-2023-49) and the Animal Welfare Ethics Committee of Beijing MDKN Biotechnology Co., LTD. (Approval number: MDKN-2024-126)., and was conducted in strict accordance with the experimental animal care and use guidelines of Beijing Animal Control Committee. Informed consent Informed consent was obtained from all subjects involved in the study. Data availability All data used to support the findings of this study are included within the article. Declaration of competing interest None disclosed.